YÖYasemin Özgür

Yasemin Özgür

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yasemin Özgür has a total of 35 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Ineffectiveness of therapeutic plasma exchange as a last resort in severe COVID‐19 cases: Experience from a tertiary intensive care unit

    by Mesut Ayer, Yasemin Özgür, Güldem Turan, Nurgül Özgür Yurttaş, Yusuf Ulusoy, Şevket Ali Ekmen, Didem Hanoğlu, Edibe Sevde Eker, Şeniz Öngören

    Aim: Several studies have suggested that cytokine release syndrome (CRS) can be controlled by therapeutic plasma exchange (TPE) treatment. In this study, it was aimed to evaluate the efficacy of TPE treatment in patients who developed life‐threatening respiratory failure syndrome (SARS) due to COVID‐19 infection.Methods: In this retrospective, case–control study, patients, who developed SARS, were infected with the COVID‐19 virus, and required intensive care unit (ICU) admission were included. Patients included in the study were divided into groups according to whether TPE experience or not and if so, how many sessions were applied. Mortality rates of patients in the ICU and 30‐day mortality ratios were evaluated.Results: A total of 110 patients, 71.8% of whom were male, with a mean age of 59.7 ± 13.3 years, were included in our study. It was observed that 70% of the patients died within a month and 80% of them died during the ICU follow‐up period. The 30‐day mortality rates of patients who underwent TPE at least once and those who never underwent TPE were 72.2% and 67.9%, respectively (p: 0.617). CRP, D‐dimer, fibrinogen and platelet levels showed to have a decreasing trend after plasmapheresis and fluctuated thereafter. It was observed that procalcitonin and IL‐6 levels were increased in the group that underwent plasmapheresis but decreased in those who did not receive plasmapheresis.Conclusion: Patients severely infected with SARS‐CoV‐2 showed fluctuations in inflammatory parameters despite TPE treatment; CRS was not suppressed by TPE; and this treatment did not confer survival benefit in this patient group.

  • Immunotherapy in Acute Leukemias

    by Yasemin Ozgur, Leylagul Kaynar

    Immunotherapeutic agents have made remarkable progress in the treatment of acute leukemia. CAR T cell therapy, particularly CD19 and BCMA-targeted CAR-T cells, has shown promising results with high response rates and long remission durations. However, these therapies can be challenging to manage and may present serious toxicities, requiring careful monitoring. Despite the challenges in AML CAR-T cell therapy, new approaches targeting CD33, CD123, and other antigens hold potential for effective treatment options in these patients. In ALL, anti-CD19, anti-CD22 agents, and even CAR-T cell therapies have started to find their place in practical use. With these developments, the integration of immunotherapies into personalized treatment plans is beginning to open new horizons in leukemia treatment.

  • Metabolic Syndrome and Benign Prostatic Hyperplasia/What Component of Metabolic Syndrome Is Related to Benign Prostatic Hyperplasia?

    by Bahar Arıcan Tarım, Emre Çamur, Övünç Kavukoğlu, Mete Kösemen, Yasemin Özgür, Kamil Fehmi Narter


  • Review of the Cut-off Thresholds for Muscle Masses in Diagnosis of Sarcopenia and Creation of a New Appendicular Muscle Mass Estimation Equation Suitable for the Turkish Population

    by Yasemin Özgür, Nurhan Aliye Sayaca, Cemal Fırat Subaşı, Özcan Keskin

    Objective: The aim of our study is to compile the muscle mass index and cut-off levels of the height squared-, weight-, and body mass index-adjusted models, used in the literature for the diagnosis of sarcopenia. The study also aims to create a new appendicular skeletal muscle mass estimation equation for non-segmental bio-impedance analyzer and to determine the relationship between all these muscle mass indices and muscle strength. Methods: Body composition was assessed with bio-impedance analyzer, and muscle strength was assessed by hand grip strength with hand dynamometer. Absolute muscle mass, fat free mass, skeletal muscle mass, and appendicular skeletal muscle mass levels measured by bio-impedance-analyzer were calculated with the estimation equations defined in the literature; separately, height-, weight-, and body mass-indexed models were created. The averages of these indices, 2 standard deviation low, as well as correlation analysis with hand grip strength were performed. Multiple linear regression analyses were performed to construct the appendicular skeletal muscle mass estimation equation. Results: A total of 200 young healthy individuals aged 18-40 years (50% male) were included in the study. The cut-off thresholds were 28/16 for hand grip strength; 20.1/13.3 kg for appendicular skeletal muscle mass; 7.0/5.4 kg/m2 for appendicular skeletal muscle mass/height squared; 29.7/22.8% for appendicular skeletal muscle mass/weight; 0.81/0.56 for appendicular skeletal muscle mass/body mass index based on 2 standard deviation lower in men and women, respectively. The linear regression analysis, which has a high correlation with hand grip strength (r: 0.719; P < .001), the appendicular skeletal muscle mass estimation, quite strong (adjusted R2: 0.959), was presented as a new equation: ASMM = 3.567 + (0.119 × h2/Z) + (4.323 × gender) + (0.164 × weight). The height squared in cm2; for gender men = 1 and women = 0; weight in kg; Z is bio-impedance-analyzer impedance in 50 Ω frequency. Conclusion: This study showed us that body mass index-adjusted models were more strongly correlated with muscle strength than both height- and weight-indexed models, which differ from those commonly used in the literature.


  • Open Access

    Ramazan Orucu Tutan Diabetes Mellitus Hastalarında Kendi Kendine Glikoz Takibinin Glisemik Kontrole Etkisi

    by Nazire Aladağ, Seydahmet Akin, Yasemin Özgür, Banu Böyük, Özcan Keski̇n

    Background: It is known that a significant number of patients with diabetes insist on fasting in the month of Ramadan, despite the advice of their physicians and reliable authorities. In order to provide the best possible care and support to these patients, the International Diabetes Federation (IDF) and the Diabetes and Ramadan (DAR) International Alliance practical guidelines have been created by the International Alliance. The aim of this study was to investigate the effect of consulting a physician and self glucose monitoring on diabetes management during Ramadan in patients with fasting diabetes. Methods: With this retrospective observational study, patients over 18 years of age who were diagnosed with diabetes, who came to the diabetes outpatient clinic for control after Ramadan and who made their follow-up from our outpatient clinic before Ramadan, were included. Everyone who intends to fast (previous or not) has been asked about previous fasting experiences, questions about whether they consulted the doctor before Ramadan, and those who fasted, how they spent this Ramadan, the questionnaire was filled. The biochemical data of fasting patients before and after Ramadan were analyzed. Results: A total of 394 patients with diabetes participated in the questionnaire and 98 of them (24.9 %) who were fasted were included in the study. The mean age of the fasting patients with diabetes was 59.7 ± 12.3 years and 39.2 % were female. It was detected that 86.7 % of the fasting people were fasting for more than 15 days. Fasting rates were higher in males than females (32.4 % to 20.8%) It was found that 25.9% of patients with type 2 DM and 10.3% of patients with type 1 DM were fasting. It was determined that 62.8 % of the patients intending to fast were consulted to the physician about this subject, 55.3% of them were determined risk by physician and 70% of them followed up with self blood glucose monitoring. It was determined that 23.4 % (23/98) of fasting patients had a reduction in the number or dose of diabetes medications used; 5.1% (5/98) experienced a complication that would disrupt fasting; 16.3 % gained weight (2.8 ± 2.4 kg) and 23.5 % lost weight (2.7 ± 1.9 kg). A significant increase in HbA1c and a significant decrease in UACR were detected. It has been determined that A1c control of those who follow personal blood glucose is better protected than those who do not. Conclusion: The most valuable result of this study is that the diabetic patients have achieved a more successful diabetes control by providing self-auto control mechanism with glucose monitoring, regardless of whether or not they have received medical advice by physician consultation in Ramadan.


  • Open Access

    Uric acid albumin ratio as a predictive marker of short-term mortality in patients with acute kidney injury

    by Yasemin Özgür, Seydahmet Akın, Nuran Gamze Yılmaz, Murat Gücün, Özcan Keskin

    We aimed to investigate uric acid and albumin ratio (UA/A) as a marker of short-term mortality in acute kidney injury (AKI). Both uric acid and albumin are strongly correlated with the development and mortality of AKI. The patients hospitalized from May 2019 to September 2019 for AKI were included in this study. The diagnostic odds ratio (DOR), Youden index (J), and the area under a receiver operating characteristic curve (AUROC) determined a cut-off UA/A ratio for mortality. Cox-regression analysis was performed to identify UA/A as a prognostic marker of the 30-day mortality rate. A total of 171 patients with an average age of 69.20±13.0 (45.6% women) were included in the study. The average UA/A ratio was 3.3±1.5 mg/g and 2.5±1.0 mg/g in the non-survivor and survivor groups, respectively (P=0.001). The best cut-off UA/A ratio associated with mortality was determined as 2.4 mg/g with a specificity of 52% and a sensitivity of 77% (DOR, 3.6; J, 28.8; AUROC, 0.644). Thirty-day cumulative survival rates of the low and high UA/A ratio groups were 85.9±4.0% and 63.7±5.0%, respectively. The estimated survival times of the low and high UA/A ratio groups were 27.7 days (95% confidence interval [CI], 26.2–29.3) and 23.9 days (95% Cl, 22.0–25.9), respectively. We found a direct correlation between 30-day mortality and UA/A ratio at initial presentation in AKI patients regardless of age, comorbidities, and clinical and laboratory findings, including albuminuria.


  • Communication Effort Score (CES) in patients hospitalized in internal medicine ward

    by Yasemin Özgür, Nihal Lermi

    Aims: There are more than thirty prognostic scoring systems defined in the literature for emergency patients up to now. The purpose of this study is to develop communication effort score (CES) to be used in internal medicine ward by considering it from a different angle, and also to examine the relation of this index with prognosis. Methods: The study had a prospective-observational study design, and was conducted on patients followed-up in the ward due to acute diseases. The patients were graded under 4 categories according to communication effort within the first 8 hours after referring to emergency department, between exhibiting active communication effort and being closed to communication.The prognostic performance of CES was tested comparatively with other scoring systems by using AUROC analysis. Results: Data were collected on 308 consecutive acute medical admissions, 55.2% of whom were men, with the mean age of 65.4 ± 15.6 years The mortality rate of the patients in hospital was 2% in CES-1, 4.8% in CES-2, 27.2% in CES-3; and 51.6% in CES-4.The CES model showed a good discrimination power for in-hospital mortality as 0.813 AUC(95% CI, 0.77–0.85). These results were better than the prognostic scoring systems (RAPS, MEWS, REMS, WPS, GAP, and NEWS) and the other specific and general descriptive scoring systems (ECOG, GCS, qSOFA, CCL). The sensitivity and specificity of CES for the optimal cut-off point (2.5) in predicting in-hospital mortality were 0.957 and 0.632, respectively. Conclusions: The present study showed that CES, which is a new definitive score, is a strong predictor of both inhospital mortality and short-term mortality.

  • Open Access

    Peripheral arterial disease diagnosed by ankle–brachial index: Predictor for early renal replacement therapy in chronic kidney disease

    by Yasemin Ozgur, Seydahmet Akin, Ergun Parmaksiz, Meral Meşe, Zerrin Bicik Bahcebasi, Ozcan Keskin

    Our study aimed to investigate the relationship between ankle-brachial index (ABI) and need for early renal replacement therapy (RRT) in predialysis patients with chronic kidney disease (CKD). A total of 112 patients (62% men) with pre-dialysis CKD, seen in the outpatient clinic, were included, and ABI was obtained as per standard protocol. Peripheral arterial disease (PAD) was defined as ABI 1.3 in either leg. The clinical data were analyzed, and the risk factors for early RRT were determined by multivariate logistic regression analysis. The prevalence of PAD was 44% in predialysis CKD patients. Over three years’ follow- up, 14.2% required RRT; 11.3% developed major cardiovascular event (myocardial infarction, stroke, or death). A total of 26 events occurred. The incidence of all events was significantly higher in patients with abnormal ABI than in those with normal ABI (34.7% vs. 12.7%; log rank P = 0.02). PAD was associated with all events [hazard ratio (HR): 2.72; 95% CI: 1.04-7.17; P = 0.042] as also the need for RRT (HR 3.2; 95% Cl: 1.005-10.23; P = 0.049), on univariate cox proportional hazard analysis. Multivariate logistic regression analysis adjusted for other risk factors identified that PAD remained an independent predictor for the need for early RRT (HR: 12.2; 95%Cl: 2.2-66.5; P = 0.004) and all events (HR: 3.5; 95% Cl: 0.9-13.5; P = 0.032). PAD was an independent predictor for RRT requirement in predialysis CKD.


  • Relationship between diabetic neuropathy and sarcopenia

    by Özgür Yasemin, Akın Seydahmet, Keskin Özcan